Kojić Damjanov Sunčica, Đerić Mirjana, Eremić Kojić Nevena
Med Pregl. 2014 Sep-Oct;67(9-10):339-44.
GLYCATED HEMOGLOBIN STRUCTURE AND SYNTHESIS OF MOLECULE: Glycated hemoglobin A1c, the major fraction of glycated hemoglobin, is formed by irreversible nonenzymatic glycation. Its concentration depends only on the life span of red blood cells and blood glucose levels. CLINICAL SIGNIFICANCE OF GLYCATED HEMOGLOBIN A1c: It is the key parameter for monitoring the regulation of diabetes and for assessing the risk of microvascular complications. It is a diagnostic criterion for diabetes as well. Its concentration reflects the average value of blood glucose over the last two to three months. The estimated average glucose, a new parameter which facilitates the patient's self-monitoring of diabetes, can be calculated from its value. METHODS FOR DETERMINING GLYCATED HEMOGLOBIN A1c AND THEIR STANDARDIZATION: Immunoassay and ion-exchange chromatography are commonly used methods for the glycated hemoglobin determination in routine laboratory practice. The advantage of immunoassay is that there is no need for the sample pre-treatment in order to eliminate unstable glycated hemoglobin A1c intermediary forms, and the possibility of false positive results is lower. The current program of standardization requires traceability to the International Federation of Clinical Chemistry and Laboratory Medicine reference method. REPORTING AND INTERPRETATION OF RESULTS OF GLYCATED HEMOGLOBIN A1c DETERMINATION: Glycated Hemoglobin A1c can be reported as % or as mmol/mol. In our country, it is recommended to use the International Federation of Clinical Chemistry and Laboratory Medicine units (mmol/mol). When interpreting the results, the potential causes of falsely high or low values must always be taken into consideration.
Periodic determinations of glycated hemoglobin A1c are recommended for monitoring of diabetes regulation. Additionally, the determination is recommended for the diagnosis of diabetes. The target value for the prevention of microvascular complications is < 7% and the diagnostic criterion for diabetes is 6.5%.
糖化血红蛋白的分子结构与合成:糖化血红蛋白A1c是糖化血红蛋白的主要组分,由不可逆的非酶糖基化形成。其浓度仅取决于红细胞寿命和血糖水平。糖化血红蛋白A1c的临床意义:它是监测糖尿病病情控制及评估微血管并发症风险的关键参数。它也是糖尿病的诊断标准。其浓度反映过去两到三个月的血糖平均值。可根据其值计算估计平均血糖,这是一个有助于患者自我监测糖尿病的新参数。糖化血红蛋白A1c的测定方法及其标准化:免疫测定法和离子交换色谱法是临床常规实验室检测糖化血红蛋白常用的方法。免疫测定法的优点是无需对样品进行预处理以消除不稳定的糖化血红蛋白A1c中间形式,且出现假阳性结果的可能性较低。当前的标准化程序要求可追溯至国际临床化学和检验医学联合会的参考方法。糖化血红蛋白A1c测定结果的报告与解读:糖化血红蛋白A1c可以报告为%或mmol/mol。在我国,建议使用国际临床化学和检验医学联合会的单位(mmol/mol)。解读结果时,必须始终考虑导致值假性升高或降低的潜在原因。
建议定期测定糖化血红蛋白A1c以监测糖尿病病情。此外,也建议将其用于糖尿病的诊断。预防微血管并发症的目标值为<7%,糖尿病的诊断标准为6.5%。